Dr. Steven Kaplan from Aspergo on Urology Times

Dr. Steven Kaplan from Aspergo has recently made a presentation on the Urology Times about the rationale for an oral formulation of sildenafil for ED. It’s largely unknown that there is a significant food effect that changes the absorption of common PDE5 inhibitors (sildenafil, vardenafil and tadalafil). Dr. Kaplan goes in-depth via video interview on Aspergo Labs’ introduction of an oral spray to treat ED.